Editorial: Targeted Immunotherapy for Cancer
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_32d98d7777d44c2ba5080df1e749fcd0 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Williams V. Williams |e author |
245 | 0 | 0 | |a Editorial: Targeted Immunotherapy for Cancer |
260 | |b Frontiers Media S.A., |c 2022-04-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2022.894681 | ||
546 | |a EN | ||
690 | |a Cancer | ||
690 | |a Immunotherapy | ||
690 | |a Targeted immunotherapy | ||
690 | |a Immune modulation-immunological terms | ||
690 | |a targeted (selective) treatment | ||
690 | |a Immune checkpoint inhibitor | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 13 (2022) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2022.894681/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/32d98d7777d44c2ba5080df1e749fcd0 |z Connect to this object online. |